BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7656206)

  • 1. Mesenchymal chondrosarcoma. A cytogenetic, immunohistochemical and ultrastructural study.
    Dobin SM; Donner LR; Speights VO
    Cancer Genet Cytogenet; 1995 Aug; 83(1):56-60. PubMed ID: 7656206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mesenchymal chondrosarcoma of a child with the reciprocal translocation (11;22)(q24;q12).
    Sainati L; Scapinello A; Montaldi A; Bolcato S; Ninfo V; Carli M; Basso G
    Cancer Genet Cytogenet; 1993 Dec; 71(2):144-7. PubMed ID: 8281518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma.
    Naumann S; Krallman PA; Unni KK; Fidler ME; Neff JR; Bridge JA
    Mod Pathol; 2002 May; 15(5):572-6. PubMed ID: 12011263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic study of extraskeletal mesenchymal chondrosarcoma. A case report.
    Szymanska J; Tarkkanen M; Wiklund T; Virolainen M; Blomqvist C; Asko-Seljavaara S; Tukiainen E; Elomaa I; Knuutila S
    Cancer Genet Cytogenet; 1996 Feb; 86(2):170-3. PubMed ID: 8603349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 8 as the sole cytogenetic abnormality in a case of extraskeletal mesenchymal chondrosarcoma.
    Gatter KM; Olson S; Lawce H; Rader AE
    Cancer Genet Cytogenet; 2005 Jun; 159(2):151-4. PubMed ID: 15899388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.
    Panagopoulos I; Gorunova L; Bjerkehagen B; Boye K; Heim S
    Oncol Rep; 2014 Jul; 32(1):40-4. PubMed ID: 24839999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.
    El Beaino M; Roszik J; Livingston JA; Wang WL; Lazar AJ; Amini B; Subbiah V; Lewis V; Conley AP
    Curr Oncol Rep; 2018 Mar; 20(5):37. PubMed ID: 29582189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic findings in 19 malignant bone tumors.
    Ozisik YY; Meloni AM; Peier A; Altungoz O; Spanier SS; Zalupski MM; Leong SP; Sandberg AA
    Cancer; 1994 Oct; 74(8):2268-75. PubMed ID: 7922978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
    de Andrea CE; San-Julian M; Bovée JVMG
    Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion.
    Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
    Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
    Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
    Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
    Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas.
    Aigner T; Loos S; Müller S; Sandell LJ; Unni KK; Kirchner T
    Am J Pathol; 2000 Apr; 156(4):1327-35. PubMed ID: 10751358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue culture, DNA flow cytometric and cytogenetic studies of a giant cell tumor of bone.
    Su CC; Tzeng CC; Chow NH; Lin CJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Dec; 48(6):419-26. PubMed ID: 1664279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.
    Hameetman L; Kok P; Eilers PH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    Virchows Arch; 2005 Apr; 446(4):430-7. PubMed ID: 15744499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic findings in clear cell chondrosarcoma.
    Nishio J; Reith JD; Ogose A; Maale G; Neff JR; Bridge JA
    Cancer Genet Cytogenet; 2005 Oct; 162(1):74-7. PubMed ID: 16157204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal chondrosarcoma of the hyoid bone: a case report.
    Joo M; Kang YK; Kim HS; Lee HK; Park YK
    J Korean Med Sci; 1998 Dec; 13(6):696-700. PubMed ID: 9886185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic and immunohistochemical study of 23 cases of mesenchymal chondrosarcoma].
    Pang ZG; He XZ; Wu LY; Wei W; Liu XY; Liao DY; Li FY; Zhang XL
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):368-72. PubMed ID: 21914343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periosteal mesenchymal chondrosarcoma of the tibia with multifocal bone metastases: a case report.
    Kumar R; Duran C; Amini B; Araujo DM; Wang WL
    Skeletal Radiol; 2017 Jul; 46(7):995-1000. PubMed ID: 28352960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.